|
| [May 14, 2008] |
 |
Hercules Technology's Kathy Conte to Lead Life Sciences Workshop at TiEcon 2008 Conference in Santa Clara
PALO ALTO, Calif. --(Business Wire)-- Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC), the premier specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science companies at all stages of development, today announced that Kathy Conte, managing director of life sciences, and Richard M. Ferarri, managing director of De Novo Ventures, will be co-leading a workshop at the TiEcon 2008 Conference in Santa Clara, May 16-17, 2008. They will be conducting the Life Sciences Lunch Session entitled, "Funding the Dream: The Basics of Investment Capital," on Saturday, May 17, at 12:30 p.m. PT.
The theme of this year's TiEcon conference, "Entrepreneurship Unbounded: Inspiration from the Frontlines," reinforces Hercules' corporate mission to support the entrepreneurs of today with the capital resources, experience and expertise to guide them toward reaching important milestones.
TiEcon's annual event is touted as the largest convention in the world dedicated to entrepreneurs. A set of panel sessions will address the latest trends in Internet, mobile, software, services, new media, consumer devices, clean tech and life sciences. More than 4,000 attendees are expected at this year's event, including CEOs of mature companies, first time entrepreneurs creating new companies, financial market experts, government policy makers as well as eminent personalities from academics and media.
TiE is a global, not-for-profit, non-political and non-religious organization dedicated to fostering entrepreneurs across its international network. Since its founding in 1992, TiE has grown to become the world's largest organization for entrepreneurs and professionals, with membership spread across 48 chapters in 11 countries.
About Hercules Technology Growth Capital, Inc.:
Hercules Technology Growth Capital, Inc. is a NASDAQ traded specialty finance company providing debt and equity growth capital to technology and life science companies at all stages of development. Founded in December 2003, the company primarily finances privately held companies backed by leading venture capital and private equity firms. Hercules invests in a broad range of ventures active in technology and life science industries and offers a full suite of growth capital products at all levels of the capital structure. The company is headquartered in Palo Alto, Calif. and has additional offices in the Boston, Boulder, San Diego, Columbus and Chicago areas. Providing capital to publicly-traded or privately-held companies backed by leading venture capital and private equity firms involves a high degree of credit risk and may result in potential losses of capital. For more information, please visit www.HTGC.com.
Forward-Looking Statements:
The statements contained in this release that are not purely historical are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties and other factors we identify from time to time in our filings with the Securities and Exchange Commission. Although we believe that the assumptions on which these forward-looking statements are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Hercules assumes no obligation to update the forward-looking statements for subsequent events.
[ Back To TMCnet.com's Homepage ]
|
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO West, September 16-18, 2008. Los Angeles, California.
